LATEST UPDATES » Vol 23, No 11, November 2019 – Evaluating cost effectiveness of genomic profiling       » Ion treatment offers new hope for cancer patients       » Empowering sustainability through innovation       » Meeting clinical needs in Asia with HealthTech       » The key in diagnosis and treatment       » Singapore's first private co-working laboratory and office space       » Singapore-based MedTech company announced as winner of 2019 Asia Pacific Showcase Competition at The MedTech Forum      
Mount Alvernia Hospital appoints ICON SOC to build new state-of-the-art integrated cancer centre
Planning of the $25 million facility has commenced, with services set to open for cancer patients in late 2020.

Mount Alvernia Hospital has appointed Icon SOC, a well-established cancer care provider in Singapore, to build and manage a new state-of-the-art integrated cancer centre on site. The centre will provide a holistic approach to cancer care by bringing together medical oncology, haematology and radiation oncology for Singaporeans in need of best-practice treatment.

Icon and Mount Alvernia Hospital’s inves tment in the new integrated cancer centre is in response to one of Singapore’s fastest growing healthcare demands. Cancer is currently the leading cause of death in Singapore, accounting for 29.1 per cent of deaths in 2017. About 37 people in Singapore are diagnosed with cancer every day.

With advancements in cancer treatments, survival rates for patients with cancer has improved over the years. The early detection and screening for some of the common cancers have led to more timey treatment for many patients.

Taking a holistic approach to cancer care, the upcoming facility will offer a 10-chair day oncology hospital delivering chemotherapy, immunotherapy and targeted therapy, a radiation therapy centre with the latest Linear Accelerator and capacity for a second machine, onsite PET-CT, pathology and pharmacy services. The centre has the capacity to treat up to 1000 patients a year, including the 20 per cent of patients who require concurrent chemotherapy and radiation.

“As the risk of cancer increases with age, the number of people being diagnosed and living with cancer is likely to continue to rise on the back of an ageing population. We are very privileged to appoint and partner with Icon to support our patients and journey with them during their treatment, together providing holistic care for cancer patients in Singapore. This partnership reflects our commitment to provide patients with the full continuum of care at the time they most need it,” said Dr James Lam Kian Ming, Chief Executive Officer, Mount Alvernia Hospital.

The new centre will be equipped with the latest Varian TrueBeam Linear Accelerator, state-of-the-art technology which provides advanced precision and speed in radiation therapy.

“As an early adopter of the latest treatments in cancer care, including the first in Australasia to introduce HyperArc to treat advanced brain metastases, this centre will mean patients have access to best-practice cancer care earlier. A combination of world class expertise and state-of-the-art technology is central to our commitment and investment in Singapore and Asia,” said Mark Middleton, Group Chief Executive Officer, Icon Group.

Icon’s global partnership with Varian will see this centre become the regional training hub for radiation oncologists, medical physicists and radiation therapists in the Asia-Pacific region. “Varian is delighted to be selected by both Icon and Mount Alvernia Hospital to bring the best possible radiation oncology technology and techniques to Singaporeans, while delivering vital training for specialist clinicians. Building workforce capability and capacity to deliver world-class radiation therapy is something cancer patients across the APAC region deserve,” said Mr Kenneth Tan, President, Oncology Systems Asia Pacific, Varian Medical Systems.

Icon has a strong history of investing in best-practice cancer care in the region, including recent announcements to bring care to residents in Chongqing and Qingdao across China.

Click here for the complete issue.

news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
What's cracking — Antibodies in ostrich eggs
Clinical trials — What's in a name?
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
Healthy Ageing — How Science is chipping in
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
Evaluating cost effectiveness of genomic profiling
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy